IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents

Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same

Info

Publication number: IL142063A0
Authority: IL; Israel
Prior art keywords: tetrahydropyridoether; derivatives; same; pharmaceutical compositions; compositions containing
Prior art date: 1998-09-23

Application number

IL14206399A

Other languages

English (en)

Original Assignee

Byk Gulden Lomberg Chem Fab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-23

Filing date

1999-09-17

Publication date

2002-03-10

1999-09-17 Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab

2002-03-10 Publication of IL142063A0 publication Critical patent/IL142063A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL14206399A 1998-09-23 1999-09-17 Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same IL142063A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19843504		1998-09-23
EP98117988		1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en)	1998-09-23	1999-09-17	Tetrahydropyridoethers

Publications (1)

Publication Number	Publication Date
IL142063A0 true IL142063A0 (en)	2002-03-10

Family

ID=26049024

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14206399A IL142063A0 (en)	1998-09-23	1999-09-17	Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
IL142063A IL142063A (en)	1998-09-23	2001-03-18	History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL142063A IL142063A (en)	1998-09-23	2001-03-18	History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Country Status (31)

Country	Link
US (4)	US6436953B1 (cs)
EP (1)	EP1115725B1 (cs)
JP (1)	JP4145492B2 (cs)
KR (1)	KR100668400B1 (cs)
CN (2)	CN1155598C (cs)
AT (1)	ATE231862T1 (cs)
AU (1)	AU763463B2 (cs)
BG (1)	BG65195B1 (cs)
BR (1)	BR9914044A (cs)
CA (1)	CA2344251A1 (cs)
CZ (1)	CZ292335B6 (cs)
DE (1)	DE69905178T2 (cs)
DK (1)	DK1115725T3 (cs)
EA (1)	EA005377B1 (cs)
EE (1)	EE04677B1 (cs)
ES (1)	ES2191464T3 (cs)
GE (1)	GEP20032926B (cs)
HK (1)	HK1038360B (cs)
HR (1)	HRP20010224A2 (cs)
HU (1)	HUP0102990A3 (cs)
ID (1)	ID28896A (cs)
IL (2)	IL142063A0 (cs)
NO (1)	NO317304B1 (cs)
NZ (1)	NZ510610A (cs)
PL (1)	PL193616B1 (cs)
PT (1)	PT1115725E (cs)
RS (1)	RS50145B (cs)
SI (1)	SI1115725T1 (cs)
SK (1)	SK285165B6 (cs)
TR (1)	TR200100805T2 (cs)
WO (1)	WO2000017200A1 (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL193616B1 (pl)	1998-09-23	2007-02-28	Altana Pharma Ag	Tetrahydropirydoetery
SI1173439T1 (en)	1999-04-17	2003-10-31	Altana Pharma Ag	Haloalkoxy imidazonaphthyridines
CA2285516C (en) *	1999-05-12	2010-12-07	President And Fellows Of Harvard College	Dopamine transporter imaging agents
ATE356131T1 (de) *	2000-03-29	2007-03-15	Altana Pharma Ag	Tricyclische imidazopyridine
BR0109483A (pt) *	2000-03-29	2003-06-10	Altana Pharma Ag	Pró-drogas de derivados de imidazopiridina
CA2426616A1 (en) *	2000-10-25	2002-05-02	Altana Pharma Ag	Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk)	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
IL157461A0 (en) *	2001-03-08	2004-03-28	Astrazeneca Ab Astrazeneca Ab	Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
US6927292B2 (en)	2001-08-02	2005-08-09	Altana Pharma Ag	Tricyclic epoxides
KR20040023697A (ko) *	2001-08-03	2004-03-18	알타나 파마 아게	위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
WO2003014120A1 (en) *	2001-08-03	2003-02-20	Altana Pharma Ag	Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
JP2005519933A (ja)	2002-02-15	2005-07-07	アルタナ　ファルマ　アクチエンゲゼルシャフト	三環式ｎ−アシル化合物
MY140561A (en) *	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
PL373287A1 (en) *	2002-05-07	2005-08-22	Altana Pharma Ag	New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
CN100384842C (zh)	2002-11-19	2008-04-30	奥坦纳医药公司	8-取代的咪唑并吡啶类化合物
ATE405275T1 (de)	2002-12-12	2008-09-15	Nycomed Gmbh	Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
PL375933A1 (en) *	2002-12-20	2005-12-12	Altana Pharma Ag	8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
WO2004071391A2 (en) *	2003-02-17	2004-08-26	Altana Pharma Ag	Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
EP1606261B1 (en)	2003-03-10	2009-11-04	Nycomed GmbH	Novel process for the preparation of roflumilast
TW200503783A (en) *	2003-04-11	2005-02-01	Altana Pharma Ag	Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) *	2003-05-14	2008-05-04	التانا فاروا ايه جي	مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
WO2004105795A1 (en) *	2003-05-27	2004-12-09	Altana Pharma Ag	Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
WO2005021040A2 (en) *	2003-08-29	2005-03-10	Dynogen Pharmaceuticals, Inc.	Compositions useful for treating gastrointestinal motility disorders
CA2538419C (en)	2003-09-16	2012-07-03	Altana Pharma Ag	Use of ciclesonide for the treatment of respiratory diseases
CN1874772A (zh) *	2003-11-03	2006-12-06	阿斯利康(瑞典)有限公司	治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
WO2005058894A1 (en)	2003-12-19	2005-06-30	Altana Pharma Ag	Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) *	2004-02-17	2006-01-25	Altana Pharma Ag	Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
US8148529B2 (en)	2004-09-03	2012-04-03	Yuhan Corporation	Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
BRPI0514695A (pt)	2004-09-03	2008-06-17	Yuhan Corp	derivados de pirrol[3, 2-b]piridina e processos para a preparação destes
KR100958830B1 (ko)	2004-09-03	2010-05-24	주식회사유한양행	피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
EP1861074B1 (en) *	2005-03-16	2013-04-24	Takeda GmbH	Taste masked dosage form containing roflumilast
EP2080513A1 (en)	2008-01-16	2009-07-22	Schraermeyer, Ulrich, Prof. Dr. rer. nat	Tetrahydropyridoethers for treatment of AMD
JP5802898B2 (ja)	2009-07-09	2015-11-04	ラクオリア創薬株式会社	消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) *	2010-08-23	2012-03-01	Schering Corporation	Fused tricyclic inhibitors of mammalian target of rapamycin
WO2013187727A1 (en) *	2012-06-15	2013-12-19	Bio-Pharm Solutions Co., Ltd.	Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
US20160235724A1 (en)	2013-10-08	2016-08-18	Katairo Gmbh	Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4468400A (en) *	1982-12-20	1984-08-28	Schering Corporation	Antiulcer tricyclic imidazo [1,2-a]pyridines
KR890701585A (ko)	1987-07-16	1989-12-21	헤르베르크 슈키·울리히 볼프	새로운 디아졸
SE9401197D0 (sv) *	1994-04-11	1994-04-11	Astra Ab	Active compounds
NZ290819A (en) *	1994-07-28	1998-06-26	Byk Gulden Lomberg Chem Fab	Acyl 8-benzyloxy- or 8-benzylaminoimidazopyridines
EA002402B1 (ru) *	1997-03-24	2002-04-25	Бык Гульден Ломберг Хемише Фабрик Гмбх	Тетрагидропиридо-соединения
HUP0001555A3 (en) *	1997-10-30	2001-01-29	Altana Pharma Ag	Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) *	1998-09-23	2007-02-28	Altana Pharma Ag	Tetrahydropirydoetery

1999
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active IP Right Cessation
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en active IP Right Grant
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
- 2001-03-23 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
2002
- 2002-01-03 HK HK02100042.6A patent/HK1038360B/zh not_active IP Right Cessation
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL142063A (en)	2007-10-31
PL346617A1 (en)	2002-02-25
CN1560055A (zh)	2005-01-05
ATE231862T1 (de)	2003-02-15
HK1038360A1 (en)	2002-03-15
WO2000017200A1 (en)	2000-03-30
CN1319101A (zh)	2001-10-24
BG105270A (en)	2001-11-30
HUP0102990A3 (en)	2002-09-30
BG65195B1 (bg)	2007-06-29
CZ20011082A3 (cs)	2001-09-12
HRP20010224A2 (en)	2002-04-30
NZ510610A (en)	2003-07-25
DE69905178T2 (de)	2003-07-17
EE200100172A (et)	2002-06-17
DK1115725T3 (da)	2003-06-23
NO317304B1 (no)	2004-10-04
JP4145492B2 (ja)	2008-09-03
US7105676B2 (en)	2006-09-12
US6696460B2 (en)	2004-02-24
EP1115725A1 (en)	2001-07-18
SI1115725T1 (en)	2003-06-30
ID28896A (id)	2001-07-12
HUP0102990A2 (hu)	2002-01-28
BR9914044A (pt)	2001-12-04
EA200100315A1 (ru)	2001-10-22
AU6192099A (en)	2000-04-10
US6436953B1 (en)	2002-08-20
CZ292335B6 (cs)	2003-09-17
RS50145B (sr)	2009-03-25
PL193616B1 (pl)	2007-02-28
NO20011243D0 (no)	2001-03-12
YU21401A (sh)	2004-03-12
CA2344251A1 (en)	2000-03-30
CN100506821C (zh)	2009-07-01
JP2002526499A (ja)	2002-08-20
KR100668400B1 (ko)	2007-01-17
SK285165B6 (sk)	2006-07-07
DE69905178D1 (de)	2003-03-06
NO20011243L (no)	2001-03-12
HK1038360B (zh)	2003-05-16
US7393860B1 (en)	2008-07-01
PT1115725E (pt)	2003-06-30
AU763463B2 (en)	2003-07-24
GEP20032926B (en)	2003-03-25
CN1155598C (zh)	2004-06-30
EP1115725B1 (en)	2003-01-29
US20020169320A1 (en)	2002-11-14
KR20010075223A (ko)	2001-08-09
EE04677B1 (et)	2006-08-15
US20040162310A1 (en)	2004-08-19
TR200100805T2 (tr)	2001-08-21
ES2191464T3 (es)	2003-09-01
EA005377B1 (ru)	2005-02-24
SK3992001A3 (en)	2001-12-03

Legal Events

Date	Code	Title	Description
2008-03-23	FF	Patent granted
2008-07-09	KB	Patent renewed

Publication	Publication Date	Title
IL142063A0 (en)	2002-03-10	Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
HUP0200450A3 (en)	2004-04-28	Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP0104204A3 (en)	2002-06-28	Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof
AU2001230892A1 (en)	2001-07-31	Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
HUP0203142A3 (en)	2003-03-28	Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HK1031869A1 (en)	2001-06-29	1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
HUP0102313A3 (en)	2002-10-28	Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates
HUP0101813A3 (en)	2002-10-28	Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them
HUP0103913A3 (en)	2003-01-28	Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU4949800A (en)	2000-12-18	2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
HUP0000450A3 (en)	2001-02-28	The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases
HUP0204157A3 (en)	2005-04-28	1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP9900386A3 (en)	1999-12-28	Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
HUP0002171A3 (en)	2002-12-28	Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof
HUP0200816A2 (en)	2002-08-28	Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases, process for their preparation and pharmaceutical compositions containing them
IL141165A0 (en)	2002-11-10	New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
EP1411056A3 (en)	2004-04-28	Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation
HUP0103004A3 (en)	2003-03-28	Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them
HUP0202988A3 (en)	2004-12-28	Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
PL328123A1 (en)	1999-01-18	Derivatives of banzo[c]quinolysine and method of obtaining them
PL352280A1 (en)	2003-08-11	Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives
AU5101798A (en)	1998-06-29	Method for oral administration of buspirone
HUP0001773A3 (en)	2002-12-28	Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
CY2392B1 (en)	2004-09-10	Method for the preparation of alpha-bromolactam derivatives.
NZ272089A (en)	1996-07-26	Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions